?缓激肽B1受体抗体Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Kinins are important biologically active peptides that mediate cardiovascular homeostasis, inflammation and nociception. Bradykinin, the major effector peptide of the kallikrein-kinin system, is regulated by angiotensin-converting enzyme (ACE), which degrades the peptide.缓激肽B1受体抗体 Bradykinin normally exerts its effects through the activation of two seven transmembrane G-protein coupled receptors, named B1 and B2. The B2 receptor is constitutively expressed and preferentially binds full length bradykinin. Deletion of the B2 receptor leads to salt-sensitive hypertension and altered nociception in mice. The B1 receptor binds to derivatives of bradykinin and kallidin, which are produced by carboxypeptidase action to generate the products des-Arg9-bradykinin and des-Arg10-kallidin, respectively.缓激肽B1受体抗体 The expression of the B1 receptor is inducible by inflammatory mediators, such as bacterial lipopolysaccharide (LPS) and cytokines. The B1 and B2 receptors represent potential therapeutic targets for treatment of inflammatory disorders and cardiovascular diseases.
缓激肽B1受体抗体Also known as:
B1 bradykinin receptor; B1BKR; B1R; BDKR B1; BDKRB 1; BDKRB1; BK 1 receptor; BK-1 receptor; bradykinin B1 R; BKB1R; BKR 1; BKR1; BKRB1_HUMAN; BRADY B1; BRADYB1; Bradykinin B1 receptor; Bradykinin receptor 1; bradykinin B1R; Bradykinin receptor B1
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Rabbit, .
●
缓激肽B1受体抗体Immunogen: KLH conjugated synthetic peptide derived from Human BDKRB1.
●
Predicted Molecular Weight: 40kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl985Hu01上皮型脂肪酸结合蛋白(FABP5)多克隆抗体Polyclonal Antibody to Fatty Acid Binding Protein 5, Epidermal (FABP5)
kl985Mu01上皮型脂肪酸结合蛋白(FABP5)多克隆抗体Polyclonal Antibody to Fatty Acid Binding Protein 5, Epidermal (FABP5)
kl986Bo01血红素结合蛋白(HPX)多克隆抗体Polyclonal Antibody to Hemopexin (HPX)
kl987Hu01蛋白激酶N2(PKN2)多克隆抗体Polyclonal Antibody to Protein Kinase N2 (PKN2)
kl988Hu01Toll样受体1(TLR1)多克隆抗体Polyclonal Antibody to Toll Like Receptor 1 (TLR1)
kl989Hu01Toll样受体3(TLR3)多克隆抗体Polyclonal Antibody to Toll Like Receptor 3 (TLR3)
kl990Hu01Toll样受体5(TLR5)多克隆抗体Polyclonal Antibody to Toll Like Receptor 5 (TLR5)
kl991Hu01Toll样受体8(TLR8)多克隆抗体Polyclonal Antibody to Toll Like Receptor 8 (TLR8)
kl992Hu01Toll样受体10(TLR10)多克隆抗体Polyclonal Antibody to Toll Like Receptor 10 (TLR10)
kl994Hu01抑制蛋白β2(ARRβ2)多克隆抗体Polyclonal Antibody to Arrestin Beta 2 (ARRb2)
kl995Hu01血幼素(HJV)多克隆抗体Polyclonal Antibody to Hemojuvelin (HJV)
kl995Mu01血幼素(HJV)多克隆抗体Polyclonal Antibody to Hemojuvelin (HJV)
kl995Ra01血幼素(HJV)多克隆抗体Polyclonal Antibody to Hemojuvelin (HJV)
kl996Hu01载脂蛋白C2(APOC2)多克隆抗体Polyclonal Antibody to Apolipoprotein C2 (APOC2)
kl996Ra01载脂蛋白C2(APOC2)多克隆抗体Polyclonal Antibody to Apolipoprotein C2 (APOC2)
kl997Hu01载脂蛋白A5(APOA5)多克隆抗体Polyclonal Antibody to Apolipoprotein A5 (APOA5)
kl998Hu01KSP钙黏蛋白(CDH16)多克隆抗体Polyclonal Antibody to Cadherin 16 (CDH16)
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话